HCA Healthcare, Inc. DEF 14A Filing

Ticker: HCA · Form: DEF 14A · Filed: Mar 15, 2024 · CIK: 860730

Sentiment: neutral

Topics: HCA Healthcare, DEF 14A, Executive Compensation, Corporate Governance, Proxy Statement

TL;DR

<b>HCA Healthcare, Inc. filed its DEF 14A, detailing executive compensation and corporate governance for the fiscal year 2023.</b>

AI Summary

HCA Healthcare, Inc. (HCA) filed a Proxy Statement (DEF 14A) with the SEC on March 15, 2024. HCA Healthcare, Inc. filed a DEF 14A on March 15, 2024, for the period ending April 25, 2024. The filing details executive compensation and other corporate governance matters for the fiscal year ending December 31, 2023. Specific data points related to equity awards, pension plans, and deferred compensation for both PEO and Non-PEO members are included. The company's principal executive offices are located at One Park Plaza, Nashville, TN 37203. HCA Healthcare, Inc. was formerly known as HCA Holdings, Inc. and HCA INC/TN.

Why It Matters

For investors and stakeholders tracking HCA Healthcare, Inc., this filing contains several important signals. This filing provides crucial transparency into executive compensation packages, which can influence investor perception and proxy voting decisions. Understanding the details of equity awards, pension plans, and deferred compensation helps investors assess management's alignment with shareholder interests.

Risk Assessment

Risk Level: low — HCA Healthcare, Inc. shows low risk based on this filing. The filing is a routine DEF 14A, providing standard disclosures on executive compensation and corporate governance, with no immediate red flags.

Analyst Insight

Review the executive compensation details and any shareholder proposals to inform proxy voting decisions.

Key Numbers

Key Players & Entities

FAQ

When did HCA Healthcare, Inc. file this DEF 14A?

HCA Healthcare, Inc. filed this Proxy Statement (DEF 14A) with the SEC on March 15, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by HCA Healthcare, Inc. (HCA).

Where can I read the original DEF 14A filing from HCA Healthcare, Inc.?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by HCA Healthcare, Inc..

What are the key takeaways from HCA Healthcare, Inc.'s DEF 14A?

HCA Healthcare, Inc. filed this DEF 14A on March 15, 2024. Key takeaways: HCA Healthcare, Inc. filed a DEF 14A on March 15, 2024, for the period ending April 25, 2024.. The filing details executive compensation and other corporate governance matters for the fiscal year ending December 31, 2023.. Specific data points related to equity awards, pension plans, and deferred compensation for both PEO and Non-PEO members are included..

Is HCA Healthcare, Inc. a risky investment based on this filing?

Based on this DEF 14A, HCA Healthcare, Inc. presents a relatively low-risk profile. The filing is a routine DEF 14A, providing standard disclosures on executive compensation and corporate governance, with no immediate red flags.

What should investors do after reading HCA Healthcare, Inc.'s DEF 14A?

Review the executive compensation details and any shareholder proposals to inform proxy voting decisions. The overall sentiment from this filing is neutral.

How does HCA Healthcare, Inc. compare to its industry peers?

HCA Healthcare operates within the hospital and healthcare services industry, focusing on general medical and surgical services.

Are there regulatory concerns for HCA Healthcare, Inc.?

The DEF 14A filing is a requirement under the Securities Exchange Act of 1934, mandating public companies to provide detailed information to shareholders regarding corporate actions and executive compensation.

Industry Context

HCA Healthcare operates within the hospital and healthcare services industry, focusing on general medical and surgical services.

Regulatory Implications

The DEF 14A filing is a requirement under the Securities Exchange Act of 1934, mandating public companies to provide detailed information to shareholders regarding corporate actions and executive compensation.

What Investors Should Do

  1. Analyze the Summary Compensation Table for total compensation figures of named executive officers.
  2. Examine the grants of equity awards and their vesting schedules to understand incentive structures.
  3. Review any shareholder proposals and the company's recommendations on voting matters.

Year-Over-Year Comparison

This is the initial DEF 14A filing for the period ending April 25, 2024, detailing information for the fiscal year 2023.

Filing Stats: 4,696 words · 19 min read · ~16 pages · Grade level 13.9 · Accepted 2024-03-15 16:24:19

Key Financial Figures

Filing Documents

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 55 Compensation Risk Assessment 55 Compensation Discussion and Analysis 55 Compensation Committee Report 77

Executive Compensation Tables

Executive Compensation Tables 78 2023 Summary Compensation Table 78 2023 Grants of Plan-Based Awards 80 Narrative Disclosure to 2023 Summary Compensation Table and 2023 Grants of Plan-Based Awards Table 81 Outstanding Equity Awards at 2023 Fiscal Year-End 83 Option Exercises and Stock Vested in 2023 85 2023 Pension Benefits 86 2023 Nonqualified Deferred Compensation 88 Potential Payments Upon Termination or Change in Control 89 2023 CEO Pay Ratio 95 2023 Pay Versus Performance Table 96 Narrative Disclosure to 2023 Pay Versus Performance Table 99 OTHER INFORMATION 101 Certain Relationships and Related Person Transactions 101

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 102 Audit and Compliance Committee Report 104 Where to Find Additional Information 105 Cautionary Information 105 APPENDIX A – ADJUSTED EBITDA RECONCILIATION A-1 Proxy Statement for Annual Meeting of Stockholders to be held on April 25, 2024 IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE STOCKHOLDER MEETING TO BE HELD ON THURSDAY, APRIL 25, 2024 The Company's Proxy Statement and 2023 Annual Report to Stockholders are available on our website at www.hcahealthcare.com. Additionally, and in accordance with Securities and Exchange Commission Rules, you may access our proxy materials, including the Company's Proxy Statement, form of Proxy Card and 2023 Annual Report to Stockholders, at https://materials.proxyvote.com/40412C. Certain statements contained in this proxy statement may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act. All statements other than statements of historical or current facts, including statements regarding our environmental and other corporate responsibility and sustainability plans and objectives, made in this document are forward-looking. We use words such as "anticipates," "believes," "expects," "future," "intends," and similar expressions or future or conditional tense verbs such as "will," "may," "might," "should," "would," "could" and "working" to identify forward-looking statements. Forward-looking statements reflect management's current expectations and are inherently uncertain. Actual outcomes and results may differ materially from those expressed in, or implied by, forward looking statements. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed in our 2023 Annual Report on Form 10-K and subsequent Securities and Exchange Commission filings. Website references thro

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing